Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MBT-EVOLVE: Mentalization-Based Treatment: Exploring Variability in Outcomes, Long-term Value and Experiences: A 10+ Year Follow-up of Two Types of MBT for BPD - Quantitative and Qualitative Perspectives on Long-term Functioning

NCT07509216 is registered in ClinicalTrials.gov with De Viersprong as lead sponsor.

NCT NCT07509216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07509216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MBT-EVOLVE: Mentalization-Based Treatment: Exploring Variability in Outcomes, Long-term Value and Experiences: A 10+ Year Follow-up of Two Types of MBT for BPD - Quantitative and Qualitative Perspectives on Long-term Functioning
Lead sponsor
De Viersprong
Phase
Observational
Overall status
Recruiting
Start date
April 2, 2026
Completion date
June 30, 2027
Enrollment
113 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder